ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 184 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,648,640 | +73.1% | 358,400 | +143.1% | 0.01% | +62.5% |
| Q2 2023 | $952,204 | +54.2% | 147,400 | +80.0% | 0.01% | +33.3% |
| Q1 2023 | $617,526 | -60.6% | 81,900 | -47.1% | 0.01% | -53.8% |
| Q4 2022 | $1,568,124 | -28.8% | 154,800 | -30.5% | 0.01% | -27.8% |
| Q3 2022 | $2,202,000 | +49.5% | 222,700 | +61.0% | 0.02% | +28.6% |
| Q2 2022 | $1,473,000 | +21.9% | 138,300 | +11.6% | 0.01% | +27.3% |
| Q1 2022 | $1,208,000 | +4.8% | 123,900 | +115.3% | 0.01% | -8.3% |
| Q3 2021 | $1,153,000 | – | 57,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |